Futura Medical PLC - Futura Medical Interim Results 2022

·Europe: MED3000 will be the first pan-European topical treatment for erectile dysfunction available without the need of a doctor's prescription.. o Futura expects to file a regulatory dossier with the US Food and Drug Administration by the end of September 2022, targeting marketing authorisation for MED3000 in Q1 2023 as the first major ED treatment...